Mark Zuckerberg backed Cellular Intelligence buys STEM-PD from Novo Nordisk
NewsBytes | May 11, 2026 10:39 PM CST
Cellular Intelligence plans AI-driven STEM-PD development
Now, Cellular Intelligence plans to use its own AI tools to fast-track development and cut costs for STEM-PD.
The therapy already has FDA fast-track status, which means it could reach patients sooner if trials go well.
CEO Micha Breakstone called this move "It marks the beginning of an AI-native era for cell replacement therapy, one where biology is no longer destiny, but design,"
The company has backing from big names like Khosla Ventures and the Chan Zuckerberg Initiative, raising over $60 million so far.
READ NEXT
-
Surya Mudra is helpful in providing relief from asthma, reduces stress and calms the mind!
-
An ancient Shiva temple situated on the shores of the Arabian Sea which was also visited by Prime Minister Modi, know how to visit Somnath Temple…
-
Why modern parents feel more sleep deprived than earlier generations
-
Free Fire Max: Be careful when buying diamonds! One mistake can lead to account hack, remember these tips
-
Spotify turns 20, gifts users with a unique experience tracing their listening journeys
